Guillain-Barré syndrome presenting with COVID-19 infection

BMJ Case Reports - Tập 13 Số 9 - Trang e236978 - 2020
Nasir Ameer1, Kalyan Mansukhbhai Shekhda1, Ann Cheesman2
1Medicine, Southend University Hospital NHS Foundation Trust, Westcliff-on-Sea, Essex, UK
2Neurology, Southend University Hospital NHS Foundation Trust, Westcliff-on-Sea, Essex, UK

Tóm tắt

A construction worker in his 30s presented three times in 4 days with progressive upper and then lower limb weakness. On the first two occasions he had no systemic symptoms, but on the third presentation he had fever and cough, starting from day 4 of weakness. Examination identified weakness in all four limbs and areflexia, suggesting a peripheral neuromuscular disorder. Investigations were consistent with Guillain-Barré syndrome and additional COVID-19 (SARS-CoV-2) infection. The patient improved after immunoglobulin treatment. At least four cases of Guillain-Barré syndrome have been reported in the literature with concurrent COVID-19 illness in whom respiratory signs appeared a few days after the onset of neurological signs. With the incubation period for COVID-19 respiratory symptoms believed to be up to 14 days, it is possible that neurological symptoms could develop before respiratory and other symptoms. During the current pandemic, presence of concurrent COVID-19 infection needs to be considered in patients presenting with Guillain-Barré syndrome.

Từ khóa


Tài liệu tham khảo

10.1016/S0140-6736(16)00339-1

10.1056/NEJMra1114525

10.1136/practneurol-2014-000937

Ren, 2020, Identification of a novel coronavirus causing severe pneumonia in human: a descriptive study, Chin Med J, 133, 1015, 10.1097/CM9.0000000000000722

Sahin, 2020, 2019 novel coronavirus (COVID-19) outbreak: a review of the current literature, EJMO, 4, 1

10.3988/jcn.2017.13.3.227

Mao, 2020, Neurologic manifestations of hospitalized patients with coronavirus disease 2019 in Wuhan, China, JAMA Neurol

Ahmed, 2020, Neurological manifestations of COVID-19 (SARS-CoV-2): a review, Front Neurol, 11, 10.3389/fneur.2020.00518

10.1016/S1474-4422(20)30109-5

Sedaghat, 2020, Guillain Barre syndrome associated with COVID-19 infection: a case report, J Clin Neurosci, 76, 233, 10.1016/j.jocn.2020.04.062

Toscano, 2020, Guillain-Barré syndrome associated with SARS-CoV-2, N Engl J Med, 382, 2574, 10.1056/NEJMc2009191

Michael B , Easton A . Coronavirus statement. Malton, North Yorkshire Encephalitis Society; 2020. https://www.encephalitis.info/blog/coronavirus

Huaxia . Beijing Hospital confirms nervous system infections by novel coronavirus. Beijing XINHUANET; 2020. http://www.xinhuanet.com/english/2020-03/05/c_138846529.htm

Camdessanche, 2020, COVID-19 may induce Guillain–Barré syndrome, Rev Neurol, 176, 516, 10.1016/j.neurol.2020.04.003

Padroni, 2020, Guillain-Barré syndrome following COVID-19: new infection, old complication?, J Neurol, 267, 1877, 10.1007/s00415-020-09849-6

Virani, 2020, Guillain-Barré syndrome associated with SARS-CoV-2 infection, IDCases, 20, 10.1016/j.idcr.2020.e00771

10.1212/NXI.0000000000000741

Varatharaj, 2020, Neurological and neuropsychiatric complications of COVID-19 in 153 patients: a UK-wide surveillance study, Lancet Psychiatry, 10.1016/S2215-0366(20)30287-X